ArticleHaematologica2021

Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy.

Katja Klausz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.